PBH – Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare InPBH
$62.95Name : Prestige Consumer Healthcare In
Sector : Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Mark. Cap: $3,098,032,128.00
EPSttm : 4.26
Prestige Consumer Healthcare In
$62.95
0.38%$0.24Float Short %
3.18
Margin Of Safety %
18
Put/Call OI Ratio
0.23
EPS Next Q Diff
0.3
EPS Last/This Y
0.21
EPS This/Next Y
0.25
Price
63.2
Target Price
84.25
Analyst Recom
1.5
Performance Q
-19.63
Relative Volume
0.65
Beta
0.41
Ticker: PBH
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-09-08 | PBH | 65.82 | 0.29 | 0.00 | 166 |
| 2025-09-09 | PBH | 66.03 | 0.28 | 0.00 | 170 |
| 2025-09-10 | PBH | 65.04 | 0.28 | 0.00 | 170 |
| 2025-09-11 | PBH | 65.04 | 0.28 | 0.00 | 170 |
| 2025-09-12 | PBH | 63.24 | 0.28 | 0.00 | 170 |
| 2025-09-15 | PBH | 62.59 | 0.27 | 999.99 | 177 |
| 2025-09-16 | PBH | 63.2 | 0.27 | 999.99 | 177 |
| 2025-09-17 | PBH | 63.82 | 0.27338129496403 | 999.99 | 177 |
| 2025-09-18 | PBH | 64.1 | 0.27 | 0.00 | 177 |
| 2025-09-19 | PBH | 63.06 | 0.26 | 0.00 | 187 |
| 2025-09-22 | PBH | 63.6 | 0.26 | 0.00 | 187 |
| 2025-09-23 | PBH | 63 | 0.24 | 0.00 | 183 |
| 2025-09-24 | PBH | 63.16 | 0.24 | 0.00 | 183 |
| 2025-09-25 | PBH | 62.72 | 0.24 | 0.00 | 183 |
| 2025-09-26 | PBH | 62.98 | 0.22 | 0.00 | 193 |
| 2025-09-29 | PBH | 61.91 | 0.22 | 0.00 | 196 |
| 2025-09-30 | PBH | 62.4 | 0.22 | 999.99 | 197 |
| 2025-10-01 | PBH | 63.37 | 0.22 | 999.99 | 197 |
| 2025-10-02 | PBH | 62.83 | 0.22 | 999.99 | 197 |
| 2025-10-03 | PBH | 64.02 | 0.22 | 999.99 | 197 |
| 2025-10-06 | PBH | 63.22 | 0.23 | 0.00 | 199 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-09-08 | PBH | 65.79 | -11.0 | 15.1 | 4.53 |
| 2025-09-09 | PBH | 66.05 | -11.0 | 13.0 | 4.53 |
| 2025-09-10 | PBH | 65.05 | -11.0 | 8.1 | 4.53 |
| 2025-09-11 | PBH | 65.02 | -11.0 | 11.9 | 4.53 |
| 2025-09-12 | PBH | 63.25 | -11.0 | 4.6 | 4.53 |
| 2025-09-15 | PBH | 62.96 | -11.0 | 10.8 | 4.53 |
| 2025-09-16 | PBH | 63.20 | -11.0 | 13.0 | 4.53 |
| 2025-09-17 | PBH | 63.87 | -11.0 | 14.8 | 4.53 |
| 2025-09-18 | PBH | 64.10 | -11.0 | 13.1 | 4.53 |
| 2025-09-19 | PBH | 63.07 | -11.0 | 7.7 | 4.53 |
| 2025-09-22 | PBH | 63.60 | -11.0 | 14.1 | 4.53 |
| 2025-09-23 | PBH | 62.95 | -11.0 | 9.3 | 4.53 |
| 2025-09-24 | PBH | 63.16 | -11.0 | 12.8 | 4.53 |
| 2025-09-25 | PBH | 62.72 | -11.0 | 9.7 | 4.53 |
| 2025-09-26 | PBH | 62.97 | -11.0 | 13.0 | 4.53 |
| 2025-09-29 | PBH | 61.92 | -11.0 | 7.6 | 4.53 |
| 2025-09-30 | PBH | 62.42 | -11.0 | 14.0 | 4.53 |
| 2025-10-01 | PBH | 63.37 | -11.0 | 16.1 | 4.53 |
| 2025-10-02 | PBH | 62.77 | -11.0 | 9.5 | 4.53 |
| 2025-10-03 | PBH | 63.99 | -11.0 | 16.9 | 4.53 |
| 2025-10-06 | PBH | 63.20 | -11.0 | 13.5 | 4.53 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-09-08 | PBH | -0.26 | 0.50 | 2.54 |
| 2025-09-09 | PBH | -0.26 | 0.50 | 2.54 |
| 2025-09-10 | PBH | -0.26 | 0.50 | 2.54 |
| 2025-09-11 | PBH | -0.26 | 0.50 | 2.92 |
| 2025-09-12 | PBH | -0.26 | 0.50 | 2.92 |
| 2025-09-15 | PBH | 0.00 | 0.47 | 2.92 |
| 2025-09-16 | PBH | 0.00 | 0.47 | 2.92 |
| 2025-09-17 | PBH | 0.00 | 0.47 | 2.92 |
| 2025-09-18 | PBH | 0.00 | 0.47 | 2.92 |
| 2025-09-19 | PBH | 0.00 | 0.47 | 2.92 |
| 2025-09-22 | PBH | 0.00 | 0.48 | 2.92 |
| 2025-09-23 | PBH | 0.00 | 0.48 | 2.92 |
| 2025-09-24 | PBH | 0.00 | 0.48 | 2.92 |
| 2025-09-25 | PBH | 0.00 | 0.48 | 3.18 |
| 2025-09-26 | PBH | 0.00 | 0.48 | 3.18 |
| 2025-09-29 | PBH | 0.00 | 0.44 | 3.18 |
| 2025-09-30 | PBH | 0.00 | 0.44 | 3.18 |
| 2025-10-01 | PBH | 0.00 | 0.44 | 3.18 |
| 2025-10-02 | PBH | 0.00 | 0.44 | 3.18 |
| 2025-10-03 | PBH | 0.00 | 0.44 | 3.18 |
| 2025-10-06 | PBH | 0.00 | 0.48 | 3.18 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.95
Avg. EPS Est. Current Quarter
0.97
Avg. EPS Est. Next Quarter
1.25
Insider Transactions
Institutional Transactions
0.48
Beta
0.41
Average Sales Estimate Current Quarter
257
Average Sales Estimate Next Quarter
296
Fair Value
74.56
Quality Score
87
Growth Score
71
Sentiment Score
48
Actual DrawDown %
29.8
Max Drawdown 5-Year %
-30.5
Target Price
84.25
P/E
14.83
Forward P/E
13.16
PEG
5.72
P/S
2.78
P/B
1.68
P/Free Cash Flow
11.61
EPS
4.26
Average EPS Est. Cur. Y
4.53
EPS Next Y. (Est.)
4.78
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
19.02
Relative Volume
0.65
Return on Equity vs Sector %
-13.6
Return on Equity vs Industry %
3.5
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
13.5
Prestige Consumer Healthcare InSector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 600
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and ear wax removal products under Debrox brand name. The company also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; motion sickness relief products under the Dramamine brand; enemas and other laxative products under the Fleet brand name; stomach upset remedies under the Gaviscon brand; cough drops under the Luden's brand; products for yeast infections in women under the Monistat brand name; lice and parasite treatments under the Nix name; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; products for dry eyes under the TheraTears brand; nasal saline sprays and washes under the Fess brand name; and oral rehydration products under the Hydralyte brand. It sells its products to mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
stock quote shares PBH – Prestige Consumer Healthcare Inc. Stock Price stock today
news today PBH – Prestige Consumer Healthcare Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch PBH – Prestige Consumer Healthcare Inc. yahoo finance google finance
stock history PBH – Prestige Consumer Healthcare Inc. invest stock market
stock prices PBH premarket after hours
ticker PBH fair value insiders trading